Kopková A, Šána J, Večeřa M, Knoflíčková D, Smrčka M, Slabý O, Fadrus P
Klin Onkol. 2018 Spring;31(Supplementum1):158-160.
Deregulated levels of miRNAs, short noncoding RNAs associated with pathogenesis of many diseases, have been observed in cerebrospinal fluid (CSF). Therefore, the analysis of CSF miRNAs in patients affected by tumors of central nervous system (CNS) might help to develop new diagnostic platform enabling more precise diagnosis. Thus, in our study we tried to optimize methodical approaches to be used for miRNA detection as RNA isolation and selection of suitable technology for global high-throughput miRNA profiling.
In the optimization phase of RNA isolation from CSF, various commercially available kits with different protocol modifications were compared. Two quantitative polymerase chain reaction panels and Next Generation Sequencing method were tested for selection of the most suitable method for miRNA comprehensive profiling.
The Urine miRNA Purification kit (Norgen) and Next Generation Sequencing was selected as the most suitable kit for RNA extraction from CSF and method for miRNA comprehensive profiling, resp.
We established a protocol for RNA isolation and miRNA comprehensive profiling in CSF clinical specimens.Key words: brain neoplasm - cerebrospinal fluid - microRNA The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study. The Editorial Board declares that the manuscript met the ICMJE recommendation for biomedical papers. This study was supported by Ministry of Health of the Czech Republic, grant No. 15-34553A. All rights reserved.Submitted: 19. 3. 2018Accepted: 10. 4. 2018.
脑脊液(CSF)中已观察到微小RNA(miRNA,与多种疾病发病机制相关的短链非编码RNA)水平失调。因此,分析中枢神经系统(CNS)肿瘤患者的脑脊液miRNA可能有助于开发新的诊断平台,实现更精确的诊断。因此,在我们的研究中,我们试图优化用于miRNA检测的方法,如RNA分离以及选择适用于全局高通量miRNA谱分析的技术。
在从脑脊液中分离RNA的优化阶段,比较了各种市售试剂盒以及不同的方案修改。测试了两个定量聚合酶链反应板和下一代测序方法,以选择最适合miRNA综合谱分析的方法。
尿液miRNA纯化试剂盒(Norgen)和下一代测序分别被选为从脑脊液中提取RNA的最合适试剂盒和miRNA综合谱分析的方法。
我们建立了脑脊液临床标本中RNA分离和miRNA综合谱分析的方案。关键词:脑肿瘤 - 脑脊液 - 微小RNA 作者声明他们在研究中使用的药物、产品或服务方面没有潜在的利益冲突。编辑委员会声明该手稿符合ICMJE对生物医学论文的推荐。本研究得到捷克共和国卫生部的支持,资助号为15 - 34553A。保留所有权利。提交日期:2018年3月19日 接受日期:2018年4月10日。